ARTÍCULOS-diagnóstico

NOTA: En esta sección se recogen artículos elaborados por autores españoles  pertenecientes a instituciones españolas.

General

  1. García-Cruces J, et al. Análisis de la demanda de detección de SARS-CoV-2 en un área de salud de España. Rev Esp Quimioter. 2020 Dec;33(6):422-429 [doi
  2. Rodríguez-Molinero A, et al. Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients. PLoS One. 2020 Oct 15;15(10):e0239571 [doi
  3. Duarte-Salles T, et al. Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study. medRxiv [Preprint]. 2020 Oct 30:2020.10.29.20222083 [doi
  4. Poblador-Plou B, et al. Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain. Int J Environ Res Public Health. 2020 Jul 17;17(14):5171 [doi
  5. Golozar A, et al. Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States. medRxiv [Preprint]. 2020 Oct 27:2020.10.25.20218875 [doi
  6. Jiménez E, et al. Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study. BMJ Open. 2020 Nov 10;10(11):e042398 [doi]
  7. Tan EH, et al. Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis. medRxiv [Preprint]. 2020 Nov 27:2020.11.24.20236802 [doi
  8. Markewitz R, et al. Clinical correlates of anti-SARS-CoV-2 antibody profiles in Spanish COVID-19 patients from a high incidence region. Sci Rep. 2021 Feb 23;11(1):4363 [doi
  9. Quintana-Díaz M, et al. Coagulation Parameters: An Efficient Measure for Predicting the Prognosis and Clinical Management of Patients with COVID-19. J Clin Med. 2020 Oct 28;9(11):3482 [doi
  10. Borobia AM, et al. A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe. J Clin Med. 2020;9(6):1733 [doi]
  11. Martos Pérez F, et al. Comorbilidad y factores pronósticos al ingreso en una cohorte COVID-19 de un hospital general. Rev Clin Esp. 2020 Jun 26;S0014-2565(20)30179-X [doi
  12. Burn E, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020 Oct 6;11(1):5009 [doi
  13. Vila-Córcoles Á, et al. Evaluación de la incidencia y perfil de riesgo de Covid-19 según comorbilidad previa en adultos ≥50 años del área de Tarragona. Rev Esp Salud Publica. 2020 Jun 26;94:e202006065
  14. Marta-Enguita J, et al. Factores de riesgo y predictores de gravedad en pacientes hospitalizados por COVID-19: análisis de 52 casos. Med Clin (Barc). 2020 Jun 25;S0025-7753(20)30401-2 [doi
  15. Prieto-Alhambra D, et al. Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118 150 cases diagnosed in outpatient settings in Spain. Int J Epidemiol. 2021 Jan 23;49(6):1930-1939 [doi
  16. Muñoz P, et al. The first 100 cases of COVID-19 in a Hospital in Madrid with a 2-month follow-up. Rev Esp Quimioter. 2020 Oct;33(5):369-378 [doi
  17. Viana-Llamas MC, et al. Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study. Med Clin (Barc). 2021 Jan 28:S0025-7753(21)00032-4 [doi
  18. Martín-Sánchez FJ, et al. Impact of Spanish Public Health Measures on Emergency Visits and COVID- 19 diagnosed cases during the pandemic in Madrid. Rev Esp Quimioter. 2020;33(4):274-277 [doi
  19. Núñez-Gil IJ, et al. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry. Intern Emerg Med. 2020 Nov 9:1–10 [doi
  20. Izquierdo Domínguez A, et al. Pérdida del sentido del olfato durante la pandemia COVID-19. Med Clin (Barc). 2020 Nov 13;155(9):403-408 [doi]  
  21. Rubio-Rivas M, et al. Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19. J Clin Med. 2020 Oct 29;9(11):3488 [doi
  22. Sisó-Almirall A, et al. Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona. PLoS One. 2020 Aug 21;15(8):e0237960 [doi
  23. Jimeno S, et al. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19. Eur J Clin Invest. 2021 Jan;51(1):e13404 [doi
  24. Gestoso-Pecellín L, et al. Recommendations for use of the diverse tests for detection of SARS-COV-2 infection. Enferm Clin. 2021 Feb;31 Suppl 1:S40-S48 [doi
  25. Blanco-Suárez A, et al. Retrospective search of SARS-CoV-2 in respiratory samples in Vallès Occidental (Barcelona, Spain) before the first case was reported. Enferm Infecc Microbiol Clin. 2020 Dec;38(10):511-512 [doi
  26. Teigell Muñoz FJ, et al. A safe protocol to identify low-risk patients with COVID-19 pneumonia for outpatient management. Intern Emerg Med. 2021 Feb 23 [doi
  27. Soriano V, et al. SARS-CoV-2 antibodies in adults in Madrid, Spain . Clin Infect Dis. 2020;ciaa769 [doi
  28. Lauxmann MA, et al. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak. Int Braz J Urol. 2020;46(suppl.1):6-18 [doi
  29. Randazzo W, et al. SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area. Water Res. 2020 May 16;181:115942 [doi]
  30. Reina J. El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo. Vacunas. 2020;21(1):17-22 [doi
  31. Infante Urrios A, et al. Serological diagnosis of SARS-CoV-2. Diagnostic rentability of a chemiluminescence test. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Oct 31:S0213-005X(20)30324-4 [doi
  32. Soriano V, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Adults in Madrid, Spain. Clin Infect Dis. 2021 Mar 15;72(6):1101-1102 [doi
  33. Izquierdo-Domínguez A, et al. Smell and taste dysfunctions in COVID-19 are associated with younger age in ambulatory settings – a multicenter cross-sectional study. J Investig Allergol Clin Immunol. 2020;0 [doi
  34. Rivera-Izquierdo M, et al. Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study. PLoS One. 2020 Jun 25;15(6):e0235107 [doi

.Alergología

  1. Barroso B, et al. Presenting prevalence, characteristics and outcome of asthmatic patients with T2 diseases in hospitalized subjects with COVID-19 in Madrid, Spain. J Investig Allergol Clin Immunol. 2020;0 [doi]
  2. Barroso B, et al. Prevalence, Characteristics, and Outcome of Asthmatic Patients With Type 2 Diseases in Hospitalized Patients With COVID-19 in Madrid, Spain. J Investig Allergol Clin Immunol. 2020;30(5):382-384 [doi
  3. Izquierdo-Domínguez A, et al. Smell and Taste Dysfunction in COVID-19 Is Associated With Younger Age in Ambulatory Settings: A Multicenter Cross-Sectional Study. J Investig Allergol Clin Immunol. 2020;30(5):346-357 [doi

Anatomía patológica

  1. COVID-19 Autopsy. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic. Rev Esp Patol. 2020;53(3):182-187 [doi
  2. Valdivia-Mazeyra MF, et al. Increased number of pulmonary megakaryocytes in COVID-19 patients with diffuse alveolar damage: an autopsy study with clinical correlation and review of the literature. Virchows Arch. 2021 Mar;478(3):487-496n [doi

Anestesiología

  1. Tornero C, et al. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial”. Trials. 2020 Jun 26;21(1):576 [doi
  2. Taboada M, et al. Critically ill COVID-19 patients attended by anesthesiologists in northwestern Spain: a multicenter prospective observational study. Rev Esp Anestesiol Reanim. 2021 Jan;68(1):10-20 [doi

Aparato digestivo

  1. Benedé-Ubieto R, et al. Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain. J Clin Med. 2021 Mar 3;10(5):1039 [doi
  2. Rodríguez-Lago I, et al. Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain). Gastroenterology. 2020 Aug;159(2):781-783 [doi
  3. Colmenero J, et al. Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2020 Aug 1;S0168-8278(20)30521-3 [doi
  4. Guerra I, et al. Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. Inflamm Bowel Dis. 2021 Jan 1;27(1):25-33 [doi
  5. Sanz Segura P, et al. Involvement of the digestive system in covid-19. A review. Gastroenterol Hepatol. 2020 Oct;43(8):464-471 [doi
  6. Vicario Bravo M, et al. Sintomatología digestiva y COVID-19: importancia de descartar patología quirúrgica asociada. Cir Esp. 2020;S0009-739X(20)30192-5 [doi]

Atención primaria

  1. Chiesa-Estomba CM, et al. La alteración del olfato y el gusto en pacientes COVID-19. Un recurso diagnóstico en atención primaria [published online ahead of print, 2020 May 27]. Aten Primaria. 2020 Oct;52(8):592-593 [doi
  2. Guisado-Clavero M, et al. Clinical characteristics of SARS-CoV-2 pneumonia diagnosed in a primary care practice in Madrid (Spain). BMC Fam Pract. 2021 Apr 29;22(1):83 [doi
  3. Montenegro P, et al. Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain. Fam Pract. 2021 Mar 29;38(2):154-159 [doi
  4. Vila-Córcoles A, et al. Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain. BMJ Open. 2020 Dec 10;10(12):e041577 [doi]

Cardiología

  1. Valdivia AR, et al. Cardiovascular examination should also include peripheral arterial evaluation for COVID-19 patients [texto completo]. J Vasc Surg. 2020 Apr 29;S0741-5214(20)31100-9 [doi]
  2. Hamadeh A, et al. Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2020 Sep 15;131:1-6 [doi
  3. Eiras S, et al. COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity. Rev Esp Cardiol (Engl Ed). 2020;73(8):691-693 [doi
  4. Gonzalez-Fernandez O, et al. D-dimer and right ventricular abnormalities as prognostic factors in critically ill COVID-19 patients. Rev Esp Cardiol (Engl Ed). 2020 Jul 16;73(11):966–8 [doi
  5. Rodríguez-Santamarta M, et al. Echocardiographic findings in critical patients with COVID-19. Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):861-863 [doi
  6. Torres González N, et al. Electrocardiographic/QT interval monitoring with a portable device in hospitalized patients with COVID-19: a protocol proposal. Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):771-773 [doi
  7. Solano-López J, et al. Factores de riesgo de muerte hospitalaria en pacientes con infarto agudo de miocardio durante la pandemia de la COVID-19. Rev Esp Cardiol. 2020 Dec;73(12):985-993 [doi
  8. Uribarri A, et al. Fibrilación auricular en pacientes con COVID-19. Utilidad de la puntuación CHA2DS2-VASc: un análisis del registro internacional HOPE COVID-19. Rev Esp Cardiol. 2021 Mar 2 [doi
  9. Bardají A, et al. Implicaciones pronósticas del daño miocárdico en pacientes con y sin diagnóstico confirmado de COVID-19 atendidos en un hospital universitario. Rev Esp Cardiol. 2021 Jan;74(1):24-32 [doi
  10. Calvo-Fernández A, et al. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis. Rev Esp Cardiol (Engl Ed). 2021 Jul;74(7):576-583 [doi
  11. Bardají A, et al. Prognostic implications of myocardial injury in patients with and without COVID-19 infection treated in a university hospital. Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):24-32 [doi
  12. Solano-López J, et al. Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak. Rev Esp Cardiol (Engl Ed). 2020 Dec;73(12):985-993 [doi
  13. Cano Carrizal R, et al. Surgical facemask: an ally of exercise stress echocardiography during the COVID-19 pandemic? Rev Esp Cardiol (Engl Ed). 2021 May;74(5):472-474 [doi]

Cirugía

  1. Pardo Aranda F. A propósito de la carta científica «Sospecha de abdomen agudo como manifestación extrapulmonar de infección COVID-19» [texto completo]. Cir Esp. 2020 Apr 22;S0009-739X(20)30138-X [doi]
  2. De Miguel Negro M, et al. Pre-operative prevalence of asymptomatic carriers of COVID-19 in hospitals in Catalonia during the first wave after the resumption of surgical activity. Cir Esp. 2021 Jan 29:S0009-739X(21)00036-1 [doi
  3. Blanco-Colino R, et al. Respuesta de autores a: A propósito de la carta científica «Sospecha de abdomen agudo como manifestación extrapulmonar de infección COVID-19» [texto completo]. Cir Esp. 2020 Apr 22;S0009-739X(20)30139-1 [doi]
  4. García Virosta M, et al. Retraso diagnóstico durante la pandemia por COVID-19: absceso hepático secundario a colecistitis aguda litiásica [texto completo]. Cir Esp. 2020 Apr 16;S0009-739X(20)30133-0 [doi]

Cuidados intensivos

  1. Ramírez P, et al. Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain. Med Intensiva. 2021 Jan-Feb;45(1):27-34 [doi
  2. Lorente L, et al. Association between red blood cell distribution width and mortality of COVID-19 patients. Anaesth Crit Care Pain Med. 2021 Feb;40(1):100777 [doi]
  3. Ferrando C, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020 Dec;46(12):2200-2211 [doi
  4. García Garmendia JL, et al. Detección viral y respuesta serológica en pacientes críticos intubados con SARS-CoV-2. Implicaciones para retirada de aislamiento. Med Intensiva. 2020 Dec;44(9):586-588 [doi
  5. Fraile Gutiérrez V, et al. Ecografía en el manejo del paciente crítico con infección por SARS-CoV-2 (COVID-19): una revisión narrativa. Med Intensiva. 2020 Dec;44(9):551-565 [doi
  6. Lorente L, et al. HLA genetic polymorphisms and prognosis of patients with COVID-19. Med Intensiva. 2021 Mar;45(2):96-103 [doi
  7. González Cortés R, et al. A multicenter national survey of children with SARS-CoV-2 infection admitted to Spanish Pediatric Intensive Care Units. Intensive Care Med. 2020;1-3 [doi
  8. Ferrando C, et al. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study. Rev Esp Anestesiol Reanim. 2020 Oct;67(8):425-437 [doi
  9. Estella Á, et al. Predictive factors of six-week mortality in critically ill patients with SARS-CoV-2: A multicenter prospective study. Med Intensiva (Engl Ed). 2021 Mar 8:S0210-5691(21)00033-4 [doi
  10. Tornero C, et al. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial”. Trials. 2020;21(1):576 [doi
  11. Rodríguez A, et al. Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic. Med Intensiva. 2020 Dec;44(9):525-533 [doi
  12. Moreno G, et al. Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients. Med Intensiva. 2021 Jan-Feb;45(1):42-55 [doi

Dermatología

  1. Docampo-Simón A, et al. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e445-e447 [doi]
  2. Carrascosa JM, et al. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19). Actas Dermosifiliogr. 2020 Nov;111(9):734-742 [doi
  3. Gómez-Fernández C, et al. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak. Int J Dermatol. 2020 Dec;59(12):1475-1484 [doi
  4. Fernandez-Nieto D, et al. Lack of skin manifestations in COVID-19 hospitalized patients during the second epidemic wave in Spain: a possible association with a novel SARS-CoV-2 variant – a cross-sectional study. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e183-e185 [doi
  5. Nuno-Gonzalez A, et al. Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings. Br J Dermatol. 2021 Jan;184(1):184-185 [doi
  6. Giavedoni P, et al. Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity. J Clin Med. 2020 Oct 12;9(10):3261 [doi

Endocrinología y nutrición

  1. Fresán U, et al. Independent Role of Severe Obesity as a Risk Factor for COVID-19 Hospitalization: A Spanish Population-Based Cohort Study. Obesity (Silver Spring). 2021 Jan;29(1):29-37 [doi

Geriatría

  1. Mostaza JM, et al. Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population. Arch Gerontol Geriatr. 2020 Jul 27;91:104204 [doi
  2. Bonanad C, t al. The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects. J Am Med Dir Assoc. 2020;21(7):915-918 [doi]
  3. Águila-Gordo D, et al. Mortalidad y factores pronósticos asociados en pacientes ancianos y muy ancianos hospitalizados con infección respiratoria COVID-19. Rev Esp Geriatr Gerontol. 2020 Nov 11:S0211-139X(20)30174-8 [doi
  4. Callejas Rubio JL, et al. Tratamiento y evolución del síndrome de tormenta de citoquinas asociados a infección por SARS-CoV-2 en pacientes octogenarios. Rev Esp Geriatr Gerontol. 2020;S0211-139X(20)30063-9 [doi
  5. Gutiérrez Rodríguez J, et al. Variables asociadas con mortalidad en una población de pacientes mayores de 80 años y con algún grado de dependencia funcional, hospitalizados por COVID-19 en un Servicio de Geriatría. Rev Esp Geriatr Gerontol. 2020 2020 Nov-Dec;55(6):317-325
  6. Ortonobes Roig S, et al. Variables clínicas y farmacológicas de pacientes nonagenarios hospitalizados por COVID-19. Rev Esp Quimioter. 2021 Apr;34(2):145-150 [doi

Hematología

  1. van Doesum J, et al. Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands. Leukemia. 2020 Sep;34(9):2536-2538 [doi
  2. Zalba Marcos S, et al. Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group. Med Clin (Barc). 2020 Oct 23;155(8):340-343 [doi]
  3. Faura A, et al. Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic. Pediatr Blood Cancer. 2020 Sep;67(9):e28557 [doi
  4. Regalado-Artamendi I, et al. Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study. Hemasphere. 2021 Feb 10;5(3):e538 [doi
  5. Piñana JL, et al. Risk factors and outcome of COVID-19 in patients with hematological malignancies. Exp Hematol Oncol. 2020 Aug 25;9:21 [doi
  6. Piñana JL, et al. Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation. J Infect Dis. 2020 Aug 29:jiaa553 [doi

Hospitales

  1. Sardiña-González C, et al. COVID 19 comprehensive management in a regional hospital of Northwestern Spain. Gac Med Mex. 2020;156(4):294-297 [doi

Inmunología

  1. Laguna-Goya R, et al. IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9 [doi

Medicina Intensiva

  1. Moreno G, et al. Revisión sistemática sobre la utilidad pronóstica del dímero-D, coagulación intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID-19. Med Intensiva. 2020 Jun 17;S0210-5691(20)30187-X [doi]

Medicina interna

  1. Carrasco-Sánchez FJ, et al. Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry. Ann Med. 2021 Dec;53(1):103-116 [doi
  2. Rodilla E, et al. Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19. J Clin Med. 2020 Sep 28;9(10):3136 [doi
  3. Vizcarra P, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020 Aug;7(8):e554-e564 [doi
  4. Parra LM, et al. Hospital Readmissions of Discharged Patients with COVID-19. Int J Gen Med. 2020 Dec 2;13:1359-1366 [doi]
  5. Carretero Gómez J, et al. La inflamación, la desnutrición y la infección por SARS-CoV-2: una combinación nefasta. Rev Clin Esp. 2020 Nov;220(8):511-517 [doi
  6. Falces-Romero I, et al. Isolation of Aspergillus spp. in respiratory samples of patients with COVID-19 in a Spanish tertiary care hospital. Mycoses. 2020 Aug 4;10.1111/myc.13155 [doi
  7. Penarrubia AL, et al. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak. Int J Infect Dis. 2020 Jun 11;S1201-9712(20)30463-X [doi]
  8. Iftimie S, et al. Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain. PLoS One. 2020 Sep 3;15(9):e0234452 [doi
  9. Marta-Enguita J, et al. Risk factors and severity predictors in COVID-19 hospitalized patients: Analysis of 52 patients. Med Clin (Barc). 2020 Oct 23;155(8):360-361 [doi
  10.  

Microbiología

  1. Berenguer J, et al. Characteristics and predictors of death among 4,035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020 Aug 4;S1198-743X(20)30431-6 [doi
  2. Martínez-Murcia A, et al. Comparative in silico design and validation of GPS™ CoVID-19 dtec-RT-qPCR Test. J Appl Microbiol. 2021 Jan;130(1):2-13 [doi
  3. Parada-Ricart E, et al. Usefulness of the antigen for diagnosing SARS-CoV-2 infection in patients with and without symptoms. Enferm Infecc Microbiol Clin. 2020 Oct 1:S0213-005X(20)30299-8 [doi

Nefrología

  1. Arenas MD, et al. Clinical Profiles in Renal Patients with COVID-19. J Clin Med. 2020 Aug 18;9(8):2665 [doi
  2. Rodrigo E, et al. Silent COVID-19 in haemodialysis facilities in Cantabria, Spain: an ecological study. Clin Kidney J. 2020 Jul 2;13(3):475-476 [doi
  3. Stock da Cunha T, et al. The Spectrum of Clinical and Serological Features of COVID-19 in Urban Hemodialysis Patients. J Clin Med. 2020 Jul 16;9(7):2264 [doi

Neonatología

  1. Martínez-Perez O, et al. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain. JAMA. 2020;e2010125 [doi]  [published correction appears in JAMA. 2020 Jul 21;324(3):305]
  2. Marín Gabriel MA, et al. Maternal, Perinatal and Neonatal Outcomes With COVID-19: A Multicenter Study of 242 Pregnancies and Their 248 Infant Newborns During Their First Month of Life. Pediatr Infect Dis J. 2020 Dec;39(12):e393-e397 [doi
  3. Rodríguez-Blanco N, et al. Revisión exploratoria sobre series de casos de coronavirus (SARS-CoV, MERS-CoV y SARS-CoV-2) y sus resultados obstétricos y neonatales. Rev Esp Quimioter. 2020 Oct;33(5):313-326 [doi

Neumología

  1. Pascual-Guàrdia S, et al. Absence of Relevant Clinical Effects of SARS-COV-2 on the Affinity of Hemoglobin for O2 in Patients with COVID-19. Arch Bronconeumol (Engl Ed). 2021 Mar 26:S0300-2896(21)00113-7 [doi
  2. Figueira Gonçalves JM, et al. Biomarkers of acute respiratory distress syndrome in adults hospitalised for severe SARS-CoV-2 infection in Tenerife Island, Spain. BMC Res Notes. 2020 Dec 9;13(1):555 [doi]
  3. Pérez Dueñas V, et al. Blue Lungs in Covid-19 Patients: A Step beyond the Diagnosis of Pulmonary Thromboembolism using MDCT with Iodine Mapping. Arch Bronconeumol. 2021 Jan;57 Suppl 1:35-46 [doi
  4. Blasco ML, et al. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia. MedRxiv. 2020 Apr 8 [doi]
  5. Jiménez-Ruiz CA, et al. COVID-19 and Smoking: A Systematic Review and Meta-Analysis of the Evidence. Arch Bronconeumol. 2021 Jan;57 Suppl 1:21-34 [doi
  6. Fragiel M, et al. Diagnóstico diferencial de la neumonía en los tiempos del COVID-19. Rev Esp Quimioter. 2020 Oct;33(5):387-389 [doi
  7. Mendoza Ferradas FJ, et al. Extensión y cuantificación de la carga inflamatoria en COVID-19 mediante tomografía computarizada. Arch Bronconeumol. 2020 Apr 2;S0300-2896(20)30100-9 [doi]
  8. Recalde-Zamacona B, et al. Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients. Thorax. 2020 Dec;75(12):1116-1118 [doi
  9. Ramos Hernández C, et al. Lung Ultrasound to Predict Unfavorable Progress in Patients Hospitalized for COVID-19. Arch Bronconeumol. 2021 Jan;57 Suppl 1:47-54 [doi
  10. Madrid Carbajal CJ, et al. PCR in Sputum for the Diagnosis of COVID-19 in a Case with Infrequent Radiological Pattern. Arch Bronconeumol. 2021 Jan;57 Suppl 1:70-71 [doi
  11. Rodriguez-Sevilla J, et al. Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer. Arch Bronconeumol. 2020 Nov;56(11):758-759 [doi
  12. Pérez Pallarés J, et al. Recomendaciones de consenso SEPAR-AEER sobre la utilidad de la ecografía torácica en el manejo del paciente con sospecha o infección confirmada con COVID-19. Arch Bronconeumol. 2020;56 Suppl 2:27-30 [doi
  13. Blanco Suárez A, et al. Retrospective search of SARS-CoV-2 in respiratory samples in Vallès Occidental (Barcelona, Spain) before the first case was reported. Enferm Infecc Microbiol Clin. 2020 Jun 11;S0213-005X(20)30218-4 [doi
  14. López-Reyes R, et al. Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach. Arch Bronconeumol. 2021 Jan;57 Suppl 1:55-64 [doi
  15. Cillóniz C, et al. The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia. Arch Bronconeumol. 2021 Jan;57 Suppl 1:79-82 [doi

Neurología

  1. Barón-Sánchez J, et al. Afectación del sentido del olfato y el gusto en la enfermedad leve por coronavirus (COVID-19) en pacientes españoles. Neurologia. 2020 Nov-Dec;35(9):633-638 [doi
  2. Martín-Jiménez P, et al. Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study. J Alzheimers Dis. 2020;78(4):1367-1372 [doi] 
  3. Romero-Sánchez CM, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020 Aug 25;95(8):e1060-e1070 [doi
  4. Abenza-Abildúa MJ, et al. Neurological complications in critical patients with COVID-19. Neurologia. 2020 Nov-Dec;35(9):621-627 [doi
  5. Fasano A, et al. Predictors of COVID-19 outcome in Parkinson’s disease. Parkinsonism Relat Disord. 2020 Sep;78:134-137 [doi

Obstetricia y Ginecología

  1. Martínez-Perez O, et al. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain. JAMA. 2020 Jul 21;324(3):296-299 [doi].  Erratum in: JAMA. 2020 Jul 21;324(3):305
  2. Gracia-Perez-Bonfils A, et al. Fetal heart rate changes on the cardiotocograph trace secondary to maternal COVID-19 infection. Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:286-293 [doi
  3. Marín Gabriel MA, et al. Maternal, Perinatal and Neonatal Outcomes With COVID-19: A Multicenter Study of 242 Pregnancies and Their 248 Infant Newborns During Their First Month of Life. Pediatr Infect Dis J. 2020 Dec;39(12):e393-e397 [doi
  4. Cuñarro-López Y, et al. Maternal and Perinatal Outcomes in Patients with Suspected COVID-19 and Their Relationship with a Negative RT-PCR Result. J Clin Med. 2020 Nov 4;9(11):3552 [doi
  5. Borrás A, et al. Pandemia del SARS-CoV-2 y reproducción asistida. Clin Invest Ginecol Obstet. 2020 Jul-Sep;47(3):96-105 [doi
  6. González Romero D, et al. Pronóstico perinatal y de la paciente embarazada con infección por COVID-19 [texto completo]. Rev Clin Esp. 2020 Apr 17 [doi
  7. Rodríguez-Blanco N, et al. Revisión exploratoria sobre series de casos de coronavirus (SARS-CoV, MERS-CoV y SARS-CoV-2) y sus resultados obstétricos y neonatales. Rev Esp Quimioter. 2020 Oct;33(5):313-326 [doi
  8. Villalaín C, et al. Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome. PLoS One. 2020 Nov 30;15(11):e0243029 [doi]
  9. Martinez-Portilla RJ, et al. A Spanish-translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women [texto completo]. Lancet Infect Dis. 2020 Jun;20(6):655 [doi]  

Oftalmología

  1. Arias-Peso B, et al. Conjunctivitis and COVID-19: The importance of an early detection. Enferm Infecc Microbiol Clin. 2021 Feb;39(2):111 [doi
  2. Güemes-Villahoz N, et al. Conjunctivitis in COVID-19 patients: frequency and clinical presentation. Graefes Arch Clin Exp Ophthalmol. 2020 Nov;258(11):2501-2507 [doi
  3. Güemes-Villahoz N, et al. Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19? J Med Virol. 2021 Jan;93(1):383-388 [doi
  4. Fanlo P, et al. Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: result of the COVID-19-GEAS patient survey. Arch Soc Esp Oftalmol. 2021 Jan 23:S0365-6691(21)00022-8 [doi
  5. Pérez-Bartolomé F, et al. Ocular manifestations of SARS-CoV-2: Literature review. Arch Soc Esp Oftalmol. 2021 Jan;96(1):32-40 [doi

Oncología

  1. Cabrera Villegas A, et al. [18F]-FDG PET/CT in oncologic patients with unsuspected asymptomatic infection with SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):786-793 [doi
  2. Kuderer NM, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907-1918 [doi
  3. Pinato DJ, et al. Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe. Cancers (Basel). 2020 Jul 8;12(7):E1841 [doi]
  4. Cabezón-Gutiérrez L, et al. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data. Cancer Treat Rev. 2020 Nov;90:102102 [doi

Otorrinolaringología

  1. Lop Gros J, et al. Alteraciones del olfato en la COVID-19, revisión de la evidencia e implicaciones en el manejo de la pandemia. Acta Otorrinolaringol Esp. 2020 Nov-Dec;71(6):379-385 [doi]
  2. Rojas-Lechuga MJ, et al. Chemosensory dysfunction in COVID-19 out-patients. Eur Arch Otorhinolaryngol. 2021 Mar;278(3):695-702 [doi
  3. Alcoba Flórez J, et al. Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples. MedRxiv. 2020 Apr 11 [doi]
  4. Martin-Villares C, et al. Outcome of 1890 tracheostomies for critical COVID-19 patients: a national cohort study in Spain. Eur Arch Otorhinolaryngol. 2020 Aug 4;1-8 [doi

Pediatría

  1. Calvo C, et al. A 14-year Prospective Study of Human Coronavirus Infections in Hospitalized Children: Comparison With Other Respiratory Viruses. Pediatr Infect Dis J. 2020 Aug;39(8):653-657 [doi]
  2. Andina D, et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020;37(3):406-411 [doi
  3. Pérez-Martinez A, et al. Clinical outcome of SARS-CoV-2 infection in immunosuppressed children in Spain. Eur J Pediatr. 2021 Mar;180(3):967-971 [doi
  4. García-Salido A, et al. Documento español de consenso sobre diagnóstico, estabilización y tratamiento del síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2 (SIM-PedS). An Pediatr (Barc). 2021 Feb;94(2):116.e1-116.e11 [doi
  5. Storch-de-Gracia P, et al. Espectro clínico y factores de riesgo de enfermedad complicada en niños ingresados con infección por SARS-CoV-2. An Pediatr (Barc). 2020 Nov;93(5):323-333 [doi
  6. Faura A, et al. Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic. Pediatr Blood Cancer. 2020 Jul 16;e28557 [doi
  7. Sánchez Tierraseca M, et al. Manifestación gastrointestinal exclusiva como forma de presentación de infección por coronavirus (COVID-19). An Pediatr (Barc). 2020;93(1):72-73 [doi
  8. Marín Gabriel MA, et al. Multi-centre Spanish study found no incidences of viral transmission in infants born to mothers with COVID-19. Acta Paediatr. 2020 Jul 10;10.1111/apa.15474 [doi
  9. Moraleda C, et al. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain. Clin Infect Dis. 2021 May 4;72(9):e397-e401 [doi]
  10. González Cortés R, et al. A multicenter national survey of children with SARS-CoV-2 infection admitted to Spanish Pediatric Intensive Care Units. Intensive Care Med. 2020 Sep;46(9):1774-1776 [doi
  11. Moreno-Galarraga L, et al. SARS-CoV-2 infection in children requiring hospitalization: the experience of Navarra, Spain. World J Pediatr. 2020 Dec;16(6):614-622 [doi
  12. Manti S, et al. SARS-CoV-2 infection in pediatric population. Acta Biomed. 2020 Sep 15;91(11-S):e2020003 [doi
  13. Melgosa M, et al. SARS-CoV-2 infection in Spanish children with chronic kidney pathologies. Pediatr Nephrol. 2020;35(8):1521-1524 [doi
  14. Tagarro A, et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain [texto completo]. JAMA Pediatr. 2020 Apr 8;10.1001/jamapediatrics.2020.1346 [doi]
  15. García-Salido A, et al. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit Care. 2020 Nov 26;24(1):666 [doi]
  16. Oliva Rodríguez-Pastor S, et al. Skin Manifestations During the COVID-19 Pandemic in the Pediatric Emergency Department. Pediatr Int. 2020 Dec 5 [doi]
  17. Brotons P, et al. Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain. Clin Infect Dis. 2021 Jun 15;72(12):e970-e977 [doi

Profesionales sanitarios

  1. Rivera-Izquierdo M, et al. Clinical Factors, Preventive Behaviours and Temporal Outcomes Associated with COVID-19 Infection in Health Professionals at a Spanish Hospital. Int J Environ Res Public Health. 2020;17(12):4305 [doi]
  2. Simón Sacristán M, et al. SARS-COV-2 Infection and Specific Antibody Detection on Health Care Workers from a Military Hospital in Madrid, Spain. Curr Microbiol. 2021 Jun 22 [doi
  3. Pérez-García F, et al. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hospital workers in a severely affected institution in Madrid, Spain: A surveillance cross-sectional study. Infect Control Hosp Epidemiol. 2020 Oct 29:1-7 [doi

Radiodiagnóstico

  1. Soriano Aguadero I, et al. Chest computed tomography findings in different phases of SARS-CoV-2 infection. Radiologia (Engl Ed). 2021 May-Jun;63(3):218-227 [doi
  2. Sánchez-Oro R, et al. Clinical and radiological findings for the new multisystem inflammatory syndrome in children associated with COVID-19. Radiologia (Engl Ed). 2021 Mar 11:S0033-8338(21)00068-0 [doi
  3. Tabik S, et al. COVIDGR Dataset and COVID-SDNet Methodology for Predicting COVID-19 Based on Chest X-Ray Images. IEEE J Biomed Health Inform. 2020 Dec;24(12):3595-3605 [doi]
  4. Joshi RC, et al. A deep learning-based COVID-19 automatic diagnostic framework using chest X-ray images. Biocybern Biomed Eng. 2021 Jan-Mar;41(1):239-254 [doi
  5. Gil-Rodrigo A, et al. Diagnostic yield of point-of-care ultrasound imaging of the lung in patients with COVID-19. Emergencias. 2020 Sep;32(5):340-344
  6. López Zúñiga D, et al. El diagnóstico COVID-19 a través de la imagen. Med Clin (Barc). 2020 Aug 14;155(3):140 [doi
  7. Mucientes Rasilla JM, et al. Diagnóstico de neumonía COVID 19 en pacientes asintomáticos tras la realización de PET-TC oncológico. Rev Esp Med Nucl Imagen Mol. 2020 Sep-Oct;39(5):299-302 [doi]
  8. Martínez Redondo J, et al. Higher Accuracy of Lung Ultrasound over Chest X-ray for Early Diagnosis of COVID-19 Pneumonia. Int J Environ Res Public Health. 2021 Mar 27;18(7):3481 [doi
  9. Ventura-Díaz S, et al. A higher D-dimer threshold for predicting pulmonary embolism in patients with COVID-19: a retrospective study. Emerg Radiol. 2020 Dec;27(6):679-689 [doi
  10. Sánchez-Oro R, et al. La radiología en el diagnóstico de la neumonía por SARS-CoV-2 (COVID-19) [texto completo]. Med Clin (Barc). 2020;S0025-7753(20)30185-8 [doi]
  11. Tung-Chen Y, et al. Lung ultrasound in the frontline diagnosis of COVID-19 infection. Med Clin (Barc). 2020 Jun 12;S0025-7753(20)30356-0 [doi
  12. Tung-Chen Y, et al. Point-of-care ultrasonography in the initial characterization of patients with COVID-19. Med Clin (Barc). 2021 Jan 28:S0025-7753(21)00015-4 [doi]
  13. Parra Gordo ML, et al. Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complications. Radiologia (Engl Ed). 2021 Jan-Feb;63(1):74-88 [doi
  14. Martínez Chamorro E, et al. Radiologic diagnosis of patients with COVID-19. Radiologia (Engl Ed). 2021 Jan-Feb;63(1):56-73 [doi
  15. Tung-Chen Y, et al. Time course of lung changes on thoracic ultrasound of mild COVID-19 patients. Enferm Infecc Microbiol Clin. 2021 Jan;39(1):46-48 [doi

Reumatología

  1. Santos CS, et al. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol. 2020 Sep;39(9):2789-2796 [doi
  2. Pablos JL, et al. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. Ann Rheum Dis. 2020 Sep;79(9):1170-1173 [doi
  3. Freites Nuñez DD, et al. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020 Nov;79(11):1393-1399 [doi

Técnicas diagnósticas

  1. Serrano-Cumplido A, et al. Aplicación del valor umbral del número de ciclos (Ct) de PCR en la COVID-19. Semergen. 2021 May 27:S1138-3593(21)00137-4 [doi
  2. Vila Muntadas M, et al. COVID-19 diagnostic tests: importance of the clinical context. Med Clin (Barc). 2021 May 6:S0025-7753(21)00214-1 [doi
  3. Cubo AM, et al. COVID-19 qPCR testing in women admitted for delivery in Spain: Is universal testing worthy?: A commentary. Arch Gynecol Obstet. 2021 Feb;303(2):601-603 [doi
  4. Reina J, et al. Detection of respiratory viruses in patients with suspected SARS-CoV-2 infection. Enferm Infecc Microbiol Clin. 2021 Jan;39(1):52-53 [doi
  5. Álvarez Argüelles ME, et al. El diagnóstico del SARS-Cov-2 y la incertidumbre radical. J Healthc Qual Res. 2020;35(4):199-201 [doi
  6. Reina J, et al. Evaluación de diferentes genes en la detección por RT-PCR del SARS-CoV-2 en muestras respiratorias y su evolución en la infección [texto completo]. Rev Esp Quimioter. 2020 May 27;reina27may2020 [doi]
  7. Pardo-Lledias J, et al. False positives in SARS-CoV-2 disease. Med Clin (Barc). 2021 Jan 28:S0025-7753(21)00020-8 [doi
  8. Alcoba-Florez J, et al. Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling. Int J Infect Dis. 2021 Feb;103:19-22 [doi
  9. López-Abente J, et al. Massive application of the SARS-CoV-2 diagnostic test: simulation of its effect on the evolution of the epidemic in Spain. Epidemiol Infect. 2020 Sep 29;148:e233 [doi
  10. Constán-Rodríguez J, et al. Rapid immunoglobulin test confirms a suspected case of COVID-19. Med Clin (Barc). 2020 Aug 28;155(4):187 [doi]
  11. Candel FJ, et al. Recommendations for use of antigenic tests in the diagnosis of acute SARS-CoV-2 infection in the second pandemic wave: attitude in different clinical settings. Rev Esp Quimioter. 2020 Dec;33(6):466-484 [doi
  12. De Salazar A, et al. Sample pooling for SARS-CoV-2 RT-PCR screening. Clin Microbiol Infect. 2020 Dec;26(12):1687.e1-1687.e5 [doi
  13. Herrero Hernando C,et al. Test de PCR a SARS-CoV-2 persistentemente positivo. No siempre la detección del virus es COVID-19. An Pediatr (Barc). 2020 Oct;93(4):264-265 [doi
  14. Revollo B, et al. ¿Test rápidos antigénicos o PCR en tiempo real para SARS-CoV-2, que test usar y por qué? Enferm Infecc Microbiol Clin. 2021 Jun 12 [doi
  15. Guisado-Clavero M, et al. Using mobile applications and websites for the diagnosis of COVID-19 in Spain. Enferm Infecc Microbiol Clin. 2020 Sep 9:S0213-005X(20)30267-6 [doi
  16. Folgueira López MD. Utilización del test de detección de antígeno de SARS-CoV-2 en exudado nasofaríngeo para el control de la infección por COVID-19. Rev Esp Quimioter. 2020 Dec;33(6):390-391 [doi]
  17. Fernandez-Montero A, et al. Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values. EClinicalMedicine. 2021 Jun 9:100954 [doi
  18. Hernández-Pérez JM, et al. Virtudes y dificultades en los test diagnósticos de la infección por el SARS-CoV-2. Med Clin (Barc). 2020 Nov 27;155(10):464-465 [doi

Trasplantes

  1. Cravedi P, et al. COVID-19 and Kidney Transplantation: Results from the TANGO International Transplant Consortium. Am J Transplant. 2020 Nov;20(11):3140-3148 [doi]
  2. Miarons M, et al. COVID-19 in Solid Organ Transplantation: A Matched Retrospective Cohort Study and Evaluation of Immunosuppression Management. Transplantation. 2021 Jan 1;105(1):138-150 [doi
  3. González J, et al. Early experience with COVID-19 in kidney transplantation recipients: update and review. Int Braz J Urol. 2020;46(suppl.1):145-155 [doi
  4. Colmenero J, et al. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients. J Hepatol. 2021 Jan;74(1):148-155 [doi
  5. Montagud-Marrahi E, et al. Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single center cohort of kidney recipients. Am J Transplant. 2020 Oct;20(10):2958-2959 [doi
  6. Crespo M, et al. Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients. Transplantation. 2020 Nov;104(11):2225-2233 [doi
  7. Loinaz C, et al. Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain. Transpl Infect Dis. 2020 Oct;22(5):e13372 [doi

Traumatología

  1. Muñoz Vives JM, et al. Mortality Rates of Patients with Proximal Femoral Fracture in a Worldwide Pandemic: Preliminary Results of the Spanish HIP-COVID Observational Study. J Bone Joint Surg Am. 2020;102(13):e69 [doi
  2. Lakhani K, et al. Nosocomial infection with SARS-CoV-2 and main outcomes after surgery within an orthopaedic surgery department in a tertiary trauma centre in Spain. Int Orthop. 2020 Dec;44(12):2505-2513 [doi

Urgencias

  1. Jiménez Hernández S, et al. Características clínicas, factores de riesgo y resultados finales de pacientes con COVID-19 diagnosticados de tromboembolia de pulmón en urgencias. Emergencias. 2020;32(4):253-257
  2. Miró Ò, et al. A case-control emergency department-based analysis of acute pancreatitis in Covid-19: Results of the UMC-19-S6. J Hepatobiliary Pancreat Sci. 2020 Dec 1:10.1002/jhbp.873 [doi] .
  3. Martín-Sánchez FJ, et al. Categorías diagnósticas y resultados a corto plazo en los pacientes con sospecha de COVID-19 atendidos en un servicio de urgencias. Emergencias. 2020;32(4):242-252
  4. Martín-Sánchez FJ, et al. Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department [published online ahead of print, 2020 Jul 16]. Eur Geriatr Med. 2020 Jul 16;1-13 [doi
  5. Alvarez-Arguelles ME, et al. El diagnóstico del SARS-Cov-2 y la incertidumbre radical. J Healthc Qual Res. 2020 Jul-Aug;35(4):199-201 [doi
  6. Gil-Rodrigo A, et al. Evaluación de las características clínicas y evolución de pacientes con COVID-19 a partir de una serie de 1000 pacientes atendidos en servicios de urgencias españoles. Emergencias. 2020;32(4):233-241
  7. Fragiel M, et al. Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19. Ann Neurol. 2021 Mar;89(3):598-603 [doi]
  8. Puerta-Alcalde P, et al. El perfil del paciente COVID-19 atendido en los servicios de urgencias españoles durante la pandemia de 2020. Emergencias. 2020;32(4):225-226
  9. Pascual Gómez NF, et al. Potenciales biomarcadores predictores de mortalidad en pacientes COVID-19 en el Servicio de Urgencias. Rev Esp Quimioter. 2020 Aug;33(4):267-273 [doi

Urología

  1. Carrion DM, et al. Assessment of trends and clinical presentation in the emergency department of patients with renal colic during the COVID-19 pandemic era. Actas Urol Esp. 2020 Dec;44(10):653-658 [doi
  2. Sánchez MD, et al. Nosocomial SARS-CoV-2 infection in urology departments: Results of a prospective multicentric study. Int J Urol. 2021 Jan;28(1):62-67 [doi